by Seini Moimoi | Sep 19, 2025
Assembly Biosciences is a biotechnology company developing innovative small-molecule therapeutics designed to treat serious viral diseases. 
by Seini Moimoi | Jun 6, 2025
Helicore Biopharma is a biotechnology company that is developing a portfolio of first-in-class GIP (glucose-dependent insulinotropic peptide) antagonists for obesity and related conditions. 
by Seini Moimoi | May 30, 2025
CytomX Therapeutics (NASDAQ: CTMX) is a clinical-stage biotechnology company developing novel conditionally activated, masked biologics designed to be localized to the tumor microenvironment. 
by Seini Moimoi | May 12, 2025
Rivus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity. 
by Seini Moimoi | Jan 16, 2025
Aviceda Therapeutics is a biotechnology company developing next-generation immunomodulators with a proprietary High Affinity Ligands of Siglecs (HALOS™) nanotechnology platform to alleviate chronic, non-resolving inflammation.